Wellgistics Health, Inc.(WGRX)Earnings, Financials & Key Ratios

Executives exercise previously issued warrants to acquire 200,000 common shares Shares issued in connection with exercise added to existing lock-up agreements TAMPA, FL / ACCESS Newswire / June 30, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™ , today announced that its Executive Chairman Suren Ajjarapu and President & Interim Co-CEO Prashant Patel have exercised all warrants previously issued to them in connection with the conversion of their outstanding salaries into common shares at $10 per share. The exercise of the warrants resulted in the issuance of a total of 200,000 to the executives.

Name reflects vertically-aligned healthcare ecosystem business model integrating data captured via telemedicine, online pharmacy, lab tests and wearables to perfect patients' digital health twins in the Health Lives Here app designed to influence/optimize behavior EinsteinRx AI™ capabilities expanding into medical, laboratory and wearables fields Pharmacy and Pharmacy Services division being rebranded as Corexa Health™ Company positioned to empower patients to seize ownership of their health data with blockchain-enabled data management to control data and participate in its monetization (1) 2,647,198 common shares outstanding, with (2) 1,333,930 of those shares locked up for at least ninety (90) days from today, and (3) 919,465 common shares deposited in DTCC, leaving (4) 80,628 cash warrants with fixed $35.00 exercise price representing only other securities currently eligible for deposit into DTCC for free trading shares TAMPA, FL / ACCESS Newswire / June 26, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™ , today announced that its management and Board of Directors has selected DataMeds AI, Inc as its new corporate name, subject to shareholder approval. The proposed new stock sticker remains MEDS.